1. Suppression effect of a dual cancer-specific oncolytic adenovirus on luciferase-labeled human melanoma cells in vitro and in vivo
   Min Li et al, 2021, Cancer Biomarkers CrossRef
2. Evolving Horizons: Adenovirus Vectors’ Timeless Influence on Cancer, Gene Therapy and Vaccines
   Prasad D. Trivedi et al, 2023, Viruses CrossRef
3. Genetic characterization of human adenoviruses in patients using metagenomic next-generation sequencing in Hubei, China, from 2018 to 2019
   Bin Fang et al, 2023, Frontiers in Microbiology CrossRef
4. Mutational profiling of low‐grade gliomas identifies prognosis and immunotherapy‐related biomarkers and tumour immune microenvironment characteristics
   Wen‐wen Lin et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
5. In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review
   Muhammad Joan Ailia et al, 2022, Vaccines CrossRef
6. Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health
   Shivani Thoidingjam et al, 2023, Translational Medicine Communications CrossRef
7. Preclinical evaluation of the gorilla‐derived HAdV‐B AdV‐lumc007 oncolytic adenovirus ‘GoraVir’ for the treatment of pancreatic ductal adenocarcinoma
   Selas T. F. Bots et al, 2024, Molecular Oncology CrossRef
8. COX7B Is a New Prognostic Biomarker and Correlates with Tumor Immunity in Esophageal Carcinoma
   Yinsen Song et al, 2023, Mediators of Inflammation CrossRef
9. Oncolytic viral therapy as promising immunotherapy against glioma
   Die Hu et al, 2023, MedComm – Future Medicine CrossRef